Sodium channel blockers are medications that help reduce abnormal electrical activity in the heart. They can also lower the risk of severe complications such as stroke or sudden cardiac death. Sodium ...

HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...

Nanjing Deheng Pharmaceutical Technology Co. Ltd. and Nanjing Delova Biotech Co. Ltd. have discovered new sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for ...

Sodium channels — which transmit sensory information from neurons to the central nervous system — are logical targets for pain treatment. Nonselective sodium channel blockers can reduce pain, but they ...

Dr. Naccarelli answers the question: 'What Is Flecainide, How Does It Work?' — -- Question: I have been placed on an antiarrhythmic drug called flecainide for my heart rhythm problem. How does it ...

Nat Clin Pract Neurol. 2008;4(3):159-169. Drug Primary clinical use Protective effect during administration in animal models? Effects of withdrawal in EAE Clinical study Phenytoin Treatment of ...

Depending on the type of irregular heartbeat (arrhythmia), medication can help slow or regulate a person’s heartbeat. Doctors will assess symptoms to decide the best medication. Medications for ...

A new study adds to evidence which suggests treating breast cancer patients with sodium channel blockers could be a promising future treatment to prevent the spread of cancer during the gap between ...

Praxis Precision Medicines has scored another midphase win in epilepsy this year, with its sodium channel inhibitor shown to reduce seizures in children with two specific types of the neurological ...